List of Seminars Held in 1996

JAN 18: Gregory R. Stuart (Graduate Student, Center for Environmental Health, University of Victoria, Canada); A study of Tris(2,3-dibromopropyl)-phosphate in big blue transgenic mice, and aflatoxin B1 in big blue mice and rats; Organized by Carcinogenesis Division
　　25: Manuel Perucho (Senior Staff Scientist and Research Director, La Jolla Cancer Research Foundation, USA); Molecular karyotyping of colorectal cancer by unbiased DNA fingerprinting; Organized by Oncogene Division
　　26: Masayoshi Tokunaga (Chief, Department of Pathology, Kagoshima City Hospital, Japan ); EB virus and gastric cancer; Organized by Genetics Division
　　29: Judith Mackay (Professor, Asian Consultancy on Tobacco Control, Hong Kong); Tobacco problems in Asian countries; Organized by Cancer Information and Epidemiology Division
　　6: J.O'D. McGee (Professor, Nuffield Department of Pathology, Oxford University, UK); The UK breast screening programme: management, epidemiology, pathology/molecular pathology aspects; Organized by Pathology Division
FEB　22: Isao Nakano (Postdoctoral Fellow, INSERM Unit 271, France); Immunogenecity of the hepatitis C virus glycoprotein E2 studied via the use of genetic immunization; Organized by Virology Division
　　26: George Thomas (Senior Group Leader, Friedrich Miescher-Institute, Switzerland); Regulation of p70^S6K: its role in mitogenesis; Organized by Carcinogenesis Division
MAR　6: Hanes J. Gross (Professor, Dean of Faculty of Chemistry and Pharmacy, Institute fur Biochemie, Universitat Wurzburg, Germany); Another heritage from the RNA world: self-excision of introns from pre-tRNAs; Organized by Biophysics Division
　　11: Jerzy Leszcznski (Professor, Department of Chemistry, Jackson State University, USA); Spontaneous DNA mutations induced by proton transfer in the guanine-cytosine base pair: a theoretical perspective; Organized by Biophysics Division
　　22: Christopher S. Potten (Chief, Department of Epithelial Biology, Paterson Institute for Cancer Research, UK); The genetic control and significance of apoptosis in the gastro-intestinal tract; Organized by Genetics Division
　　25: Sydney Shall (Professor, Cell & Molecular Biology Laboratory, University of Sussex, England); Werner's syndrome; lessons for cancer and aging; Organized by Biochemistry Division
　　26: Ruggero Montesano (Chief, Unit of Mechanisms of Carcinogenesis, International Agency for Research on Cancer, France); Genetic alterations in esophageal cancer: relevance to etiology and pathogenesis; Organized by Biochemistry Division
APR　 1: Jean-Paul Behr (Research Director, Laboratory of Genetic Chemistry, URA 1386, CNRS/ULP, Faculty of Pharmacology, France); Gene transfer with polyamine lipids and polymers; Organized by Directorﾕs Office
　　12: Curtis C. Harris (Chief, Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, USA); p53-TFIIH interactive effects in DNA repair and apoptosis; Organized by Biology Division
　　16: Mariette Gerber (Head, Group of Metabolic Epidemiology, Cancer Center, National Institute for Medical Research, France); Mediterranean diet and cancer; Organized by Epidemiology and Biostatistics Division
　　16: P. David Josephy (Professor, Department of Chemistry and Biochemistry, University of Guelph, Canada); Breast cancer and environmental chemical carcinogens: the role of peroxidases in the metabolic activation of mammary-specific carcinogens; Organized by Biochemistry Division
　　18: Mariette Gerber (Head, Group of Metabolic Epidemiology, Cancer Center, National Institute for Medical Research, France); Measurement of individual exposure to NO2 in Montpellier, France and effect on plasma antioxidants; Organized by Epidemiology and Biostatistics Division
　　18: Rene Bruno (Senior Research Scientist, Rhone-Poulenc Rorer Inc., France); Population pharmacokinetics of anticancer drugs; Organized by Pharmacology Division
MAY　2: Yasuhisa Sakurai (Professor, Tokyo Womenﾕs Medical College, Japan); Targetting of anticancer drugs with high molecular micelle; Organized by Pharmacology Division
　　10: Zhiwei Dong (Director, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, China); 1. Brief introduction of Cancer Institute and Cancer Hospital in China 2. Mortality of cancers in China 3. Antibodies for treatment and diagnosis of cancers; Organized by Directorﾕs Office
　　17: Nicholas H. Heintz (Associate Professor, Department of Pathology, American Cancer Society Research Faculty, University of Vermont College of Medicine, USA); E2F and the regulation of gene transcription and DNA replication during the cell cycle; Organized by Biology Division
　　30: Hiroshi Okamoto (Professor, Department of Biochemistry, Tohoku University School of Medicine, Japan); The CD38-cyclic ADP-ribose signaling system; Organized by Director's Office
JUN　4: Tetsuro Shirasaka (Director, Operations Center, Original Compound R&D, Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd., Japan); A novel trial for cancer chemotherapy: combination chemotherapy with 5FU and daily low dose infusion of cisplatin and information of SI; Organized by Pharmacology Division
　　12: Yoshio Ishimori (Research Associate, Environmental Engineering Laboratory, Research and Development Center, Toshiba Corporation, Japan); Development of DNA sensor for sequence-specific gene detection with a gold electrode modified with DNA probes and an electrochemically active dye; Organized by Genetics Division
　　17: John J. Kavanagh, Jr. (Associate Professor, University of Texas, MD Anderson Cancer Center, USA); Investigational drug development in ovarian cancer; Organized by Pharmacology Division
　　22: Joji Utsunomiya (Professor, Second Department of Surgery, Hyogo College of Medicine, Japan); Overview of studies on familial tumor; Organized by Director's Office
JUL　9: Hiroshi Ohshima (Chief, Unit of Endogenous Cancer Risk Factors, International Agency for Research on Cancer, France); Role of reactive nitrogen species in human carcinogenesis: importance of interactions with reactive oxygen species; Organized by Cancer Prevention Division
　　11: Hiroshi Ohshima (Chief, Unit of Endogenous Cancer Risk Factors, International Agency for Research on Cancer, France); Recent results on on-going studies on nitric oxide; Organized by Investigative Treatment Division
　　11: Takuro Nakamura (Scientist Associate, Mammalian Genetics Laboratory, ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, USA); Homeobox gene alteration in mouse and human myelogenic leukemia; Organized by Chemotherapy Division
　　18: Toru Kamata (Research Associate, Laboratory of Biochemical Physiology, National Cancer Institute, FCRDC, USA); A new signaling mechanism for mSos, the Ras guanine nucleotide exchanger; Organized by Biology Division
　　22: Akira Hayashi (Chief Medical Adviser, Division of Immunotherapy, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan); The resurrection of BCG-CWS: its single use for the start up of immune-network and its clinical effect; Organized by Directorﾕs Office
AUG　6: Hisayoshi Nakazawa (Researcher, Unit of Multistage Carcinogenesis, International Agency for Research on Cancer, WHO, France); Regulation of telomerase activity in human cells; Organized by Chemotherapy Division
　　7: Hisayoshi Nakazawa (Researcher, Unit of Multistage Carcinogenesis, International Agency for Research on Cancer, WHO, France); Molecular dissection of telomerase regulation in human cells; Organized by Investigative Treatment Division
SEP　3: Peter M. Howley (Professor and Chairman, Department of Pathology, Harvard Medical School, USA); Targeted ubiquitination of p53; Organized by Directorﾕs Office
　　5: Katsuyuki Hamada (Assistant Professor, Department of Obstetrics and Gynecology, Ehime University School of Medicine, Japan); Development of gene therapy for cervical cancer; Organized by Genetics Division
　　10: Tommaso A. Dragani (Vice director, National Cancer Institute, Italy); Genetics of lung cancer: mouse and human; Organized by Carcinogenesis Division
　　12: Kozo Kaibuchi (Professor, Division of Signal Transduction, Nara Institute of Science and Technology, Japan); Regulation of cytoskeleton and cell adhesion by small G proteins; Organized by Pathology Division
　　20: Alexander Burkle (Section Head, German Cancer Research Center, Germany); Molecular genetic approaches to modulate cellular poly(ADP-ribosyl)ation capacity; Organized by Biochemistry Division
　　25: Jean Feunteun (Associate Director, Institute Gustave-Roussy, France); Genetic predisposition to breast and ovarian cancer; Organized by Directorﾕs Office
OCT　15: Barry W. Glickman (Professor, Center for Environmental Health, University of Victoria, Canada); Use of Big Blue transgenic animals to study mechanisms of mutation; Organized by Carcinogenesis Division
　　15: Itsuro Inoue (Senior Research Associate, Howard Hughes Medical Institute, University of Utah, USA); Molecular genetics of essential hypertension: involvement of angiotensinogen; Organized by Oncogene Division
　　21: Curtis C. Harris (Chief, Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, USA); p53 modulation of the cell cycle and apoptosis; Organized by Biology Division
　　21: Irina Terenetzkaya (Senior Scientist, Institute of Physics, Ukrainian Academy of Sciences, Ukraine); Vitamin D, sunlight and cancer; Organized by Radiobiology Division
　　22: Godefridus J. Peters (Assistant Professor, Free University, The Netherlands); Synergism between gemcitabine and cisplatin; Organized by Pharmacology Division
NOV　5: Izumu Saito (Associate Professor, Laboratory of Molecular Genetics, Institute of Medical Science, University of Tokyo, Japan); Adenoviral vector and ﾒmolecular switchﾓ: its development and application; Organized by Directorﾕs Office
　　 6: Paul A. Fontelo (Staff Pathologist, Division of Gastrointestinal Pathology, Armed Forces Institute of Pathology, USA); 1. Pathology resources on the internet 2. Telepathology experience at the AFIP; Organized by Pathology Division
　　15: Adele Green (Head, Epidemiology and Population Health Unit, Queensland Institute of Medical Research, Australia); Epidemiological studies of melanoma in Queensland, Australia; Organized by Cancer Prevention Division
　　15: Bruce N. Ames (Professor, Division of Biochemistry and Molecular Biology, University of California, Berkeley, USA); Understanding the causes of aging and cancer; Organized by Cancer Prevention Division
　　20: Ross C. Donehower (Associate Professor of Medicine, Johns Hopkins University School of Medicine, USA); New anticancer drug development in USA; Organized by Pharmacology Division
　　21: Henry C. Pitot (Clinical Research Associate, Mayo Clinic, USA); Camptothecins in G. I. oncology; Organized by Pharmacology Division
　　21: Nancy Lee Harris (Professor of Pathology, Harvard University, Director of Anatomic Pathology, Massachusetts General Hospital, USA); The revised European-American classification of lymphoid neoplasms: principles and clinical implications; Organized by Pathology Division
　　25: John Weisburger (Director Emeritus, American Health Foundation, USA); Current approaches to disease prevention based on mechanisms; Organized by Carcinogenesis Division
　　26: Paul H.M. Lohman (Professor, Department of Radiation Genetics and Chemical Mutagenesis, State University of Leiden, The Netherlands); DNA repair and human disease; Organized by Carcinogenesis Division
DEC　6: Alessandro Weisz (Professor, Genetic Pathology, University of Naples, Italy) Estrogen and cell proliferation; Organized by Investigative Treatment Division
　　 9: Diana Anderson (Senior Associate, BIBRA International, UK); Congenital malformations in rodent offspring after chemical exposure of the fathers; Organized by Biochemistry Division
　　18: Fuyuki Ishikawa (Associate Professor, Department of Life Science, Tokyo Institute of Technology, Japan); Human telomeres and tumorigenesis; Organized by Radiobiology Division

List of Researchers Who Visited in 1996

The Director's Office
96 Jan 18 - 96 Mar 16: Zhiwei Dong (Director, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, China)
96 Apr 1: Jean-Paul Behr(Research Director, Laboratory of Genetic Chemistry, URA 1386, CNRS/ULP, Faculty of Pharmacology, France)
96 May 30: Hiroshi Okamoto (Professor, Department of Biochemistry, Tohoku University School of Medicine, Japan)
96 Sep 22 - 96 Oct 2: Jean Feunteun(Associate Director, Institute Gustave-Roussy, France)
Pathology DIvision
96 Jan 1 - 96 Dec 31: Ai-Min Hui(Lecturer, Hebei Medical University, China)
96 Oct 1 - 96 Dec 31: Lin Sun(Lecturer, Hebei Medical University, China)
96 Nov 1 - 96 Dec 31: Makito Emura(Professor for Experimental Oncology, Hannover Medical School, Germany)
Chemotherapy Division
96 Jan 1 - 96 Apr 2: Dae Joong Kim (Junior Researcher, Department of Pathology, National Institute of Safety Research, Ministry of Human Health and Welfare, Korea)
96 Jan 1 - 96 Dec 31: Jin Man Kim (Senior Research Engineer, R&D Supporting Team, Corporate R&D Center, Sunkyong Industries, Korea)
96 Jul 11 - 96 Jul 15: Takuro Nakamura (Scientist Associate, Mammalian Genetics Laboratory, ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, USA)
96 Aug 6 - 96 Aug 8: Hisayoshi Nakazawa (Researcher, Unit of Multistage Carcinogenesis, International Agency for Research on Cancer, WHO, France)
Biophysics Division
96 Jan 13 - 96 Mar 14: Jerzy Leszcznski (Professor, Department of Chemistry, Jackson State University, USA)
96 Mar 4 - 96 Mar 9: Hanes J. Gross (Professor, Dean of Faculty of Chemistry and Pharmacy, Institute fur Biochemie, Universitat Wurzburg, Germany)
Cancer Prevention Division
96 Jul 9 - 96 Jul 12: Hiroshi Ohshima (Chief, Unit of Endogenous Cancer Risk Factors, International Agency for Research on Cancer, France)
Genetics Division
96 Feb 11 - 96 Feb 16: Francois Kourilsky (Deputy Director, Institute Gustave-Roussy, France)
Oncogene Division
96 Jan 1 - 96 Feb 2: Manuel Perucho (Senior Staff Scientist and Research Director, La Jolla Cancer Research Foundation, USA)
96 Jan 28 - 96 Feb 16: Neal C. Goodwin (Doctoral Candidate, Division of Biological Sciences, University of Montana, USA)
96 Feb 1 - 96 Sep 28: Adam J. Oates (Student, Liverpool University, UK)
96 Sep 17 - 96 Sep 27: Har Gobind Khorana (Professor, Department of Biology and Chemistry, Massachusetts Institute of Technology, USA)
96 Oct 1 - 96 Dec 31: Li Xu (Lecturer, Department of Biochemistry, Nantong Medical College, China)
Carcinogenesis Division
96 Jan 7 - 96 Jan 19: Gregory R. Stuart (Graduate Student, Center for Environmental Health, University of Victoria, Canada)
96 Aug 26 - 96 Dec 31: Tommaso A. Dragani (Vice director, National Cancer Institute, Italy)
96 Oct 14 - 96 Oct 15: Barry W. Glickman (Professor, Center for Environmental Health, University of Victoria, Canada)
96 Nov 26 - 96 Nov 29: Paul H.M. Lohman (Professor, Department of Radiation Genetics and Chemical Mutagenesis, State University of Leiden, The Netherlands)
Epidemiology and Biostatistics Division
96 Apr 16 - 96 Apr 19: Mariette Gerber (Head, Group of Metabolic Epidemiology, Cancer Center, National Institute for Medical Research, France)
96 Nov 15: Walter Willert (Professor and Chairman, Department of Nutrition, Harvard School of Public Health, USA)

Table of Contents

List of Seminars Held in 1996

List of Researchers Who Visited in 1996

The Director's Office

Pathology DIvision

Chemotherapy Division

Biophysics Division

Cancer Prevention Division

Genetics Division

Oncogene Division

Carcinogenesis Division

Epidemiology and Biostatistics Division